CubeSmart (CUBE)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,141	9,691	10,422	9,039	12,453	6,563
Market Cap Growth	-4.66%	-7.02%	15.30%	-27.41%	89.74%	7.71%
Enterprise Value	12,552	12,674	13,466	12,194	15,112	8,646
Last Close Price	39.90	41.30	43.26	35.90	48.72	27.91
Price/FFO Ratio	-	15.71	16.02	-	-	-
Price/AFFO Ratio	-	15.71	16.14	-	-	-
PE Ratio	24.34	24.77	25.37	31.03	55.72	39.63
PS Ratio	8.29	9.07	9.88	8.54	14.69	9.66
PB Ratio	3.23	3.28	3.62	3.12	4.15	3.14
P/OCF Ratio	-	15.36	17.05	15.28	27.72	18.70
EV/Sales Ratio	11.45	11.86	12.76	11.52	17.82	12.73
EV/EBITDA Ratio	17.95	18.33	19.15	17.16	27.58	20.87
EV/EBIT Ratio	26.32	26.10	26.83	30.48	47.84	33.55
Debt / Equity Ratio	1.18	1.05	1.06	1.07	1.09	1.19
Debt / EBITDA Ratio	4.89	4.46	4.29	4.35	5.91	5.94
Asset Turnover	0.17	0.17	0.17	0.16	0.15	0.15
Quick Ratio	0.02	0.35	0.15	0.13	0.14	0.13
Current Ratio	0.04	0.44	0.20	0.19	0.39	0.20
Return on Equity (ROE)	13.04%	13.43%	14.27%	9.92%	9.07%	8.47%
Return on Assets (ROA)	4.62%	4.81%	5.00%	3.88%	3.49%	3.66%
Return on Capital (ROIC)	4.92%	5.07%	5.26%	4.07%	3.64%	3.82%
Earnings Yield	4.10%	4.04%	3.94%	3.22%	1.80%	2.52%
Dividend Yield	5.35%	4.96%	4.58%	4.96%	2.98%	4.77%
Payout Ratio	126.88%	118.05%	107.66%	132.91%	122.53%	154.72%
Buyback Yield / Dilution	-0.92%	-0.40%	-0.16%	-10.18%	-5.16%	-1.76%
Total Shareholder Return	4.43%	4.56%	4.42%	-5.22%	-2.19%	3.01%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.

SEC Filings: 10-K · 10-Q